Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection
Clinical trial NCT04980482 · COMPLETED
Trial details
- NCT number
- NCT04980482
- Sponsor
- Arbutus Biopharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-29
- Primary completion
- 2025-03-13
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.